Although recent findings suggest that exercise-induced increases in circulating adiponectin may reduce the neurotoxic load in individuals with obesity-related depression, direct evidence linking adiponectin to improved peripheral KYN clearance in humans remains limited and should be the subject of further investigation [68]. Here, ADIPOQ is linked to depressive symptom measurement.